publication venue for
- Management strategies for chalazia in pediatric patients: A scoping review.. 35:1481-1494. 2025
- Bevacizumab as adjunctive therapy in anterior persistent fetal vasculature.. 34:NP18-NP21. 2023
- Topical netarsudil for treatment of glaucoma with elevated episcleral venous pressure: A pilot investigation in sturge-weber syndrome.. 33:1969-1976. 2023
- Corneal stem cells niche and homeostasis impacts in regenerative medicine; concise review.. 33:1536-1552. 2023
- Topical cenegermin 0.002% for pediatric neurotrophic keratopathy.. 32:3420-3424. 2022
- Regression of treatment-resistant gyrate atrophy-associated intraretinal cystic spaces using long-term diet restriction: A case report.. 33:NP1-NP4. 2022
- Predictive modeling of risk factors and complications of cataract surgery.. 26:328-37. 2015
- Management strategies for chalazia in pediatric patients: A scoping review 2025
- Bevacizumab as adjunctive therapy in anterior persistent fetal vasculature 2024
- Bevacizumab as adjunctive therapy in anterior persistent fetal vasculature 2024
- Corneal stem cells niche and homeostasis impacts in regenerative medicine; concise review 2023
- Regression of treatment-resistant gyrate atrophy-associated intraretinal cystic spaces using long-term diet restriction: A case report 2023
- Topical netarsudil for treatment of glaucoma with elevated episcleral venous pressure: A pilot investigation in sturge-weber syndrome 2023
- A novel variant in the TSPAN12 gene-presenting as unilateral myopia, pediatric cataract, and heterochromia in a patient with familial exudative vitreoretinopathy 2022
- A novel variant in the TSPAN12 gene-presenting as unilateral myopia, pediatric cataract, and heterochromia in a patient with familial exudative vitreoretinopathy 2022
- Effect of inferior oblique myectomy on primary position when combined with lateral rectus recession for intermittent exotropia 2022
- Effect of inferior oblique myectomy on primary position when combined with lateral rectus recession for intermittent exotropia 2022
- Topical cenegermin 0.002% for pediatric neurotrophic keratopathy 2022
- Topical cenegermin 0.002% for pediatric neurotrophic keratopathy 2022
- Agreement profiles for rebound and applanation tonometry in normal and glaucomatous children 2019
- Agreement profiles for rebound and applanation tonometry in normal and glaucomatous children 2019